ESLA
NASDAQ
$1.08
Estrella Immunopharma Inc (ESLA)
Estrella Immunopharma, Inc., a preclinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company is headquartered in EmeryVille, California.
This company is also listed under the following ticker: ESLAW.
Website: https://www.estrellabio.comSector:
Healthcare
Industry:
Biotechnology
Buy
Target: $12 (+1011.11%)
Market Cap
$48M
Free Cash Flow Yield
-16.55%
Beta (5Y)
0.55
Price Chart
Valuation
Market Cap$48M
P/B4.13
Profitability
EBITDA-$13M
EPS-$0.39
Financial Health
Free Cash Flow Yield-16.55%
Growth & Risk
Beta (5Y)0.55
Sharpe Ratio0.58